首页> 外文期刊>Biology Open >Functional domains of the FSHD-associated DUX4 protein
【24h】

Functional domains of the FSHD-associated DUX4 protein

机译:FSHD相关的DUX4蛋白的功能域

获取原文
       

摘要

Aberrant expression of the full-length isoform of DUX4 (DUX4-FL) appears to underlie pathogenesis in facioscapulohumeral muscular dystrophy (FSHD). DUX4-FL is a transcription factor and ectopic expression of DUX4-FL is toxic to most cells. Previous studies showed that DUX4-FL-induced pathology requires intact homeodomains and that transcriptional activation required the C-terminal region. In this study, we further examined the functional domains of DUX4 by generating mutant, deletion, and fusion variants of DUX4. We compared each construct to DUX4-FL for (i) activation of a DUX4 promoter reporter, (ii) expression of the DUX4-FL target geneZSCAN4, (iii) effect on cell viability, (iv) activation of endogenous caspases, and (v) level of protein ubiquitination. Each construct produced a similarly sized effect (or lack of effect) in each assay. Thus, the ability to activate transcription determined the extent of change in multiple molecular and cellular properties that may be relevant to FSHD pathology. Transcriptional activity was mediated by the C-terminal 80 amino acids of DUX4-FL, with most activity located in the C-terminal 20 amino acids. We also found that non-toxic constructs with both homeodomains intact could act as inhibitors of DUX4-FL transcriptional activation, likely due to competition for promoter sites.This article has an associated First Person interview with the first author of the paper.
机译:DUX4(DUX4-FL)的全长同工型的异常表达似乎是面肩肱肱型肌营养不良症(FSHD)发病机理的基础。 DUX4-FL是转录因子,DUX4-FL的异位表达对大多数细胞有毒。先前的研究表明,DUX4-FL诱导的病理需要完整的同源域,转录激活需要C端区域。在这项研究中,我们通过产生DUX4的突变,缺失和融合变体进一步检查了DUX4的功能域。我们将每个构建体与DUX4-FL进行了比较(i)DUX4启动子报告子的激活,(ii)DUX4-FL目标基因ZSCAN4的表达,(iii)对细胞活力的影响,(iv)内源性半胱天冬酶的激活和(v )蛋白质泛素化水平。每个构建体在每个测定中产生相似大小的作用(或缺乏作用)。因此,激活转录的能力决定了与FSHD病理学有关的多种分子和细胞特性的变化程度。转录活性是由DUX4-FL的C端80个氨基酸介导的,大多数活性位于C端20个氨基酸。我们还发现,两个同源域都完整的无毒构建体可能是DUX4-FL转录激活的抑制剂,可能是由于竞争启动子位点所致。本文对第一人进行了第一人称采访。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号